Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
5
×
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
boston
blackstone group
bristol-myers squibb
cancer
clinical trials
david goldstein
depression
epilepsy
essential tremor
immuno-oncology
kiran reddy
major depressive disorder
national
perimenopausal depression
praxis precision medicines
precision medicine
san francisco blog main
san francisco top stories
steven petrou
aligos therapeutics
all of us
antisense oligonucleotide
baker brothers life sciences
beam therapeutics
benzodiazepine
benzodiazepines
biogen
biotech ipos
biotech week boston
blackstone life sciences
blepharitis
boulder/denver blog main
What
precision
5
×
drugs
medicine
medicines
new
praxis
research
aims
ambitious
annual
backed
benefiting
biotechs
boston
breast
cancer
cancer's
cause
central
ceo
chunk
clinical
cns
coming
conference
country
data
diagnostics
disorder
effort
emerged
epilepsy
esmo
european
genes
genetic
genomes
genomics
glimcher
groundbreaking
Language
unset
Current search:
biotech
×
precision
×
" boston blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
Ireland to Sequence 400K Genomes With New Precision Medicine Effort
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front